PMVP vs. MO

Last updated Jun 4, 2026

PMVP (PMV Pharmaceuticals, Inc.) and MO (Altria Group, Inc.) are both stocks. PMVP operates in Biotechnology (Healthcare), while MO operates in Tobacco (Consumer Defensive). Over the past 5 years, PMVP returned -48.94%/yr vs 15.82%/yr for MO. At a 0.01 correlation, their price movements are largely independent.

Performance

PMVP vs. MO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in PMV Pharmaceuticals, Inc. (PMVP) and Altria Group, Inc. (MO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, PMVP achieves a -7.20% return, which is significantly lower than MO's 23.96% return.

PMVP

• 1D: -1.69%
• 1M: -17.14%
• YTD: -7.20%
• 6M: -10.08%
• 1Y: 26.18%
• 3Y*: -41.38%
• 5Y*: -48.94%
• 10Y*: —

MO

• 1D: 1.53%
• 1M: -4.24%
• YTD: 23.96%
• 6M: 24.61%
• 1Y: 24.64%
• 3Y*: 25.16%
• 5Y*: 15.82%
• 10Y*: 7.78%

*Multi-year figures are annualized to reflect compound growth (CAGR)

PMVP vs. MO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
PMVP PMV Pharmaceuticals, Inc.	-7.20%	-17.22%	-51.29%	-64.37%	-62.34%	-62.45%	63.98%
MO Altria Group, Inc.	23.96%	18.17%	40.76%	-3.70%	4.37%	24.18%	9.33%

Correlation

The correlation between PMVP and MO is -0.12, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.12
Correlation (3Y) Calculated over the trailing 3-year period	-0.00
Correlation (5Y) Calculated over the trailing 5-year period	0.01
Correlation (All Time) Calculated using the full available price history since Sep 28, 2020	0.01

The correlation between PMVP and MO shifts across timeframes, from -0.12 (1 year) to 0.01 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap PMVP : $61.86M MO : $117.61B
EPS PMVP : -$1.48 MO : $4.79
Total Revenue (TTM) PMVP : $0.00 MO : $21.82B
Gross Profit (TTM) PMVP : -$97.00K MO : $14.80B
EBITDA (TTM) PMVP : -$80.43M MO : $11.70B

Return for Risk

PMVP vs. MO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PMVP

PMVP Risk / Return Rank: 55
PMVP Sharpe Ratio Rank: 54
PMVP Sortino Ratio Rank: 57
PMVP Omega Ratio Rank: 54
PMVP Calmar Ratio Rank: 57
PMVP Martin Ratio Rank: 55

MO

MO Risk / Return Rank: 69
MO Sharpe Ratio Rank: 73
MO Sortino Ratio Rank: 66
MO Omega Ratio Rank: 68
MO Calmar Ratio Rank: 68
MO Martin Ratio Rank: 70

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PMVP vs. MO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for PMV Pharmaceuticals, Inc. (PMVP) and Altria Group, Inc. (MO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	PMVP	MO	Difference
Sharpe ratio Return per unit of total volatility	0.36	1.10	-0.74
Sortino ratio Return per unit of downside risk	1.12	1.58	-0.47
Omega ratio Gain probability vs. loss probability	1.13	1.22	-0.09
Calmar ratio Return relative to maximum drawdown	0.73	1.51	-0.78
Martin ratio Return relative to average drawdown	1.33	3.82	-2.49
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

PMVP vs. MO - Sharpe Ratio Comparison

The current PMVP Sharpe Ratio is 0.36, which is lower than the MO Sharpe Ratio of 1.10. The chart below compares the historical Sharpe Ratios of PMVP and MO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	PMVP	MO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.36	1.10	-0.74
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.64	0.77	-1.41
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.34	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.60	0.69	-1.29

Drawdowns

PMVP vs. MO - Drawdown Comparison

The maximum PMVP drawdown since its inception was -98.64%, which is greater than MO's maximum drawdown of -65.43%. Use the drawdown chart below to compare losses from any high point for PMVP and MO.

Drawdown Indicators

	PMVP	MO	Difference
Max Drawdown Largest peak-to-trough decline	-98.64%	-65.43%	-33.21%
Max Drawdown (1Y) Largest decline over 1 year	-36.25%	-16.40%	-19.85%
Max Drawdown (3Y) Largest decline over 3 years	-90.61%	-16.40%	-74.21%
Max Drawdown (5Y) Largest decline over 5 years	-97.71%	-25.83%	-71.88%
Max Drawdown (10Y) Largest decline over 10 years	—	-53.69%	—
Current Drawdown Current decline from peak	-98.11%	-5.70%	-92.41%
Average Drawdown Average peak-to-trough decline	-79.76%	-11.93%	-67.83%
Ulcer Index Depth and duration of drawdowns from previous peaks	19.75%	6.48%	+13.27%

Volatility

PMVP vs. MO - Volatility Comparison

PMV Pharmaceuticals, Inc. (PMVP) has a higher volatility of 15.26% compared to Altria Group, Inc. (MO) at 7.41%. This indicates that PMVP's price experiences larger fluctuations and is considered to be riskier than MO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	PMVP	MO	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.26%	7.41%	+7.85%
Volatility (6M) Calculated over the trailing 6-month period	49.29%	17.18%	+32.11%
Volatility (1Y) Calculated over the trailing 1-year period	72.25%	22.42%	+49.83%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	76.48%	20.63%	+55.85%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	77.12%	22.94%	+54.18%

Dividends

PMVP vs. MO - Dividend Comparison

PMVP has not paid dividends to shareholders, while MO's dividend yield for the trailing twelve months is around 5.97%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
MO Altria Group, Inc.	5.97%	7.21%	7.65%	9.52%	8.05%	7.43%	8.29%	6.57%	6.07%	3.56%	3.48%	3.73%
PMVP PMV Pharmaceuticals, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both PMVP and MO in my portfolio?

PMVP and MO have a correlation of -0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, PMVP or MO?

PMVP has higher volatility (15.26%) compared to MO (7.41%). In terms of maximum drawdown, PMVP dropped -98.64% vs MO's -65.43%.

Which has better risk-adjusted returns?

MO currently has the higher Sharpe Ratio (1.10 vs 0.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.